<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Aridis Pharmaceuticals Inc.

    Aridis Pharmaceuticals Inc.

    Aridis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the develop...

    Aridis Pharmaceuticals, Inc. is a biopharmaceut...

    Filing Type:    PU
    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc. is a microbiome therapeutics platform company developing ...

    Seres Therapeutics, Inc. is a microbiome therap...

    Filing Type:    PU
    InnaMed, Inc.

    InnaMed, Inc.

    InnaMed is developing a comprehensive care management platform. Our team is develo...

    InnaMed is developing a comprehensive care mana...

    Amount Raised:    $1,070,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Clovis Oncology, Inc.

    Clovis Oncology, Inc.

    Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial stage biotechnolog...

    Founded in 2009, Clovis Oncology (NASDAQ: CLVS)...

    Filing Type:    PU
    Psychemedics Corporation

    Psychemedics Corporation

    Psychemedics pioneered the use of hair drug testing, and remains by far the larges...

    Psychemedics pioneered the use of hair drug tes...

    Filing Type:    PU
    Applied Science Products, Inc.

    Applied Science Products, Inc.

    Applied Science Products operates Advanced Plasma Products, Inc., a science and en...

    Applied Science Products operates Advanced Plas...

    SiNtx Technologies, Inc.

    SiNtx Technologies, Inc.

    SINTX Technologies is a commercial biomaterial company focused on using its silico...

    SINTX Technologies is a commercial biomaterial ...

    Filing Type:    PU
    Restoration Robotics, Inc.

    Restoration Robotics, Inc.

    Restoration Robotics, Inc., (San Jose, CA) is a medical device company developing ...

    Restoration Robotics, Inc., (San Jose, CA) is a...

    Filing Type:    PU
    AxoGen, Inc.

    AxoGen, Inc.

    Axogen (AXGN) is a global leader in innovative surgical solutions for peripheral n...

    Axogen (AXGN) is a global leader in innovative ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.